IL2 and ovarian carcinoma: The effect of DAB/IL2 on both peripheral blood Treg cell concentration and tumor burden has been previously examined in 4 patients with metastatic breast, lung or ovarian cancer (single infusion; 9 μg/kg or 12 μg/kg) [23].